Transverse Medical, Inc.
1 clinical trials · Sponsor
◉ Watch Transverse Medical, Inc.
| Record | Firm | Date |
|---|---|---|
| Clinical Feasibility and Evaluation Study of POINT-GUARD Embolic Protection Device During TAVR (GUARDIAN) (NCT06962371) | Transverse Medical, Inc. | 2025-04-07 |
Track Transverse Medical, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.